Core Viewpoint - Kaisheng New Materials (301069) reported significant growth in both revenue and net profit for the third quarter of 2025, indicating a strong financial performance and recovery from previous losses [1] Financial Performance - In Q3 2025, the company achieved revenue of 242 million yuan, representing a year-on-year increase of 19.96% [1] - The net profit attributable to shareholders reached 27.27 million yuan, a turnaround from a loss of 1.76 million yuan in the same period last year [1] - For the first three quarters of 2025, the company reported total revenue of 774 million yuan, up 11.22% year-on-year [1] - The net profit attributable to shareholders for the first three quarters was 116 million yuan, showing a substantial increase of 121.56% compared to the previous year [1] Dividend Announcement - The company plans to distribute a dividend of 0.5 yuan per 10 shares (including tax) [1]

（文章来源：每日经济新闻） 每经AI快讯，10月22日，凯盛新材(301069.SZ)公告称，第三季度净利润2727万元，同比增长 1,645.49%；前三季度净利润1.16亿元，同比增长121.56%。 ...

第四届董事会第三次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 一、会议召开及议案审议情况 山东凯盛新材料股份有限公司（以下简称"公司"）第四届董事会第三次会 议的会议通知于 2025 年 10 月 17 日以电子邮件的形式发出，2025 年 10 月 22 日 在公司会议室通过"现场+通讯"表决的方式召开，本次会议应出席董事 11 名， 实际出席董事 11 名。会议的召开符合《公司法》及《公司章程》的规定，合法 有效。本次会议由董事长王加荣先生主持，经与会各位董事认真讨论研究，审议 并通过了以下议案： （一）会议以 11 票赞成、0 票反对、0 票弃权的表决结果审议通过了《山 东凯盛新材料股份有限公司 2025 年第三季度报告》。 | 证券代码：301069 | 证券简称：凯盛新材 | 公告编号：2025-041 | | --- | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | | 山东凯盛新材料股份有限公司 体独立董事审核通过。 经核查，公司独立董事认为：公司增加 2025 年度日常关联交易预计 ...

| 证券代码：301069 | 证券简称：凯盛新材 | 公告编号：2025-042 | | --- | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | | 山东凯盛新材料股份有限公司 短缺或其他不良影响，符合公司战略规划和发展预期。 关于2025年前三季度利润分配预案的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 山东凯盛新材料股份有限公司（以下简称"公司"）于 2025 年 10 月 22 日召 开第四届董事会第三次会议，审议通过了《关于 2025 年前三季度利润分配预案 的议案》，现将公司 2025 年度前三季度利润分配预案具体情况公告如下： 一、利润分配预案基本情况 经公司财务部门核算，公司 2025 年前三季度合并会计报表实现归属于上市 公司股东净利润 115,755,522.87 元，母公司实现净利润 127,113,399.55 元，扣 除提取法定盈余公积金 0 元，再加上母公司未分配利润 598,702,720.29 元，母 公司可用于股东分配的利润为 704,784,062.94 元。 基于 ...

智通财经APP讯，凯盛新材(301069.SZ)发布2025年三季度报告，该公司前三季度营业收入为7.74亿元， 同比增长11.22%。归属于上市公司股东的净利润为1.16亿元，同比增长121.56%。归属于上市公司股东 的扣除非经常性损益的净利润为7903.42万元，同比增长120.41%。基本每股收益为0.2752元。 ...

每经AI快讯，凯盛新材（SZ 301069，收盘价：23.39元）10月22日晚间发布三季度业绩公告称，2025年 前三季度营收约7.74亿元，同比增加11.22%；归属于上市公司股东的净利润约1.16亿元，同比增加 121.56%；基本每股收益0.2752元，同比增加121.58%。 （记者 曾健辉） 每经头条（nbdtoutiao）——展望"十五五"|专访贺铿：必须改变以往将资金过度集中于房屋建设和基础 设施建设的倾向，更加突出民生领域投入 截至发稿，凯盛新材市值为98亿元。 ...

截至发稿，凯盛新材市值为98亿元。 每经AI快讯，凯盛新材（SZ 301069，收盘价：23.39元）10月22日晚间发布公告称，公司第四届第三次 董事会会议于2025年10月22日在公司会议室通过"现场+通讯"表决的方式召开。会议审议了《关于增加 2025年度日常关联交易预计额度的议案》等文件。 2025年1至6月份，凯盛新材的营业收入构成为：化工新材料占比99.42%，其他业务占比0.58%。 每经头条（nbdtoutiao）——展望"十五五"|专访贺铿：必须改变以往将资金过度集中于房屋建设和基础 设施建设的倾向，更加突出民生领域投入 （记者 王瀚黎） ...

凯盛新材公告，公司2025年前三季度合并会计报表实现归属于上市公司股东净利润1.16亿元，母公司实 现净利润1.27亿元。公司拟以截至2025年9月30日的总股本4.21亿股为基数，向全体股东每10股派发现金 红利0.50元（含税），送红股0股，不以公积金转增股本。本次利润分配共计派发现金红利总额为 2103.24万元。 ...

凯盛新材公告，2025年第三季度营收为2.42亿元，同比增长19.96%；净利润为2727.06万元，同比增长 1645.49%。前三季度营收为7.74亿元，同比增长11.22%；净利润为1.16亿元，同比增长121.56%。 ...

Financial Performance - The company's revenue for Q3 2025 reached ¥241,545,682.12, representing a year-on-year increase of 19.96%[5] - Net profit attributable to shareholders was ¥27,270,598.11, a significant increase of 1,645.49% compared to the same period last year[5] - The basic earnings per share (EPS) was ¥0.0648, reflecting a year-on-year growth of 1,643.57%[5] - Total operating revenue for the current period reached ¥774,099,034.83, an increase of 11.2% compared to ¥695,989,904.34 in the previous period[21] - Net profit for the current period was ¥115,755,522.87, significantly higher than ¥51,981,530.84 in the previous period, marking a growth of 122.2%[22] - Total comprehensive income attributable to the parent company reached ¥115,755,522.87, compared to ¥52,244,600.58 in the previous period, reflecting a significant increase[23] - Basic and diluted earnings per share both improved to ¥0.2752 from ¥0.1242 year-over-year, indicating strong profitability growth[23] Assets and Liabilities - Total assets at the end of Q3 2025 amounted to ¥2,445,295,360.59, an increase of 2.37% from the end of the previous year[5] - The total assets increased to ¥2,445,295,360.59 from ¥2,388,723,256.19, representing a growth of 2.4%[19] - Total liabilities decreased to ¥713,629,041.53 from ¥752,641,539.99, a reduction of 5.2%[19] - The total current liabilities decreased to ¥174,036,598.83 from ¥237,501,393.93, a decline of 26.8%[19] Equity and Shareholding - The company’s total equity attributable to shareholders increased to ¥1,731,666,319.06, a growth of 5.84% from the previous year[5] - The company's equity attributable to shareholders rose to ¥1,731,666,319.06, compared to ¥1,636,081,716.20, an increase of 5.8%[19] - Total number of common shareholders at the end of the reporting period is 31,375[11] - The largest shareholder, Huabang Life Health, holds 25.49% of shares, totaling 107,216,000 shares[11] - The second-largest shareholder, Huabang Health - Southwest Securities, holds 14.26% of shares, totaling 60,000,000 shares[11] - The total number of restricted shares at the end of the reporting period is 29,440,000, with no shares released during the period[15] Cash Flow and Investments - Cash flow from operating activities for the year-to-date was ¥67,712,718.94, up 46.91% compared to the same period last year[9] - Net cash flow from operating activities was ¥67,712,718.94, up from ¥46,091,360.16 in the previous period, showcasing enhanced operational efficiency[24] - Cash inflow from investment activities totaled ¥3,618,922,070.50, compared to ¥3,439,872,561.02 in the prior period, indicating robust investment returns[24] - The company’s investment activities generated a cash inflow of ¥22,417,733.07, a 106.63% increase compared to the same period last year[9] - Net cash flow from investment activities improved to ¥22,417,733.07 from a negative ¥337,905,321.16, highlighting a turnaround in investment performance[24] - The company reported a decrease in cash outflows from financing activities, totaling ¥43,725,462.59 compared to ¥78,396,198.59 in the previous period, indicating better cash management[24] Income and Expenses - The company reported a significant increase in other income, which reached ¥31,029,702.66, a rise of 4,582.86% year-on-year, primarily due to a technical compensation payment of ¥30 million[9] - The company’s income tax expenses rose by 110.63% to ¥19,276,166.17, driven by an increase in total profit[9] - Total operating costs amounted to ¥679,386,265.33, up from ¥653,215,521.28, reflecting a rise of 4.0%[21] - Research and development expenses were ¥39,639,076.78, slightly up from ¥39,202,196.52, indicating a focus on innovation[22] - The company reported a significant increase in operating profit to ¥104,635,557.55 from ¥61,217,575.59, reflecting a growth of 71.0%[22] Other Information - The company has no preferred shareholders or significant changes in the top ten preferred shareholders[13] - There are no changes in the shareholding structure of the top ten shareholders due to securities lending or borrowing[12] - The company did not execute any mergers or acquisitions during the reporting period, focusing instead on organic growth strategies[25] - The financial report for the third quarter was not audited, which may impact the perceived reliability of the financial data presented[25] - The company plans to adopt new accounting standards starting in 2025, which may affect future financial reporting[25]